Societal CDMO to Report Financial Results for Second Quarter 2022 on August 10, 2022
Societal CDMO (NASDAQ: SCTL) has announced it will release its Q2 2022 financial results after the market closes on August 10, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Societal CDMO (NASDAQ: SCTL) has announced it will release its Q2 2022 financial results after the market closes on August 10, 2022. A webcast to discuss the results and operational highlights will take place at 4:30 p.m. ET on the same day. As a leading contract development and manufacturing organization, Societal CDMO specializes in small molecule therapeutic development, offering comprehensive services including regulatory support and clinical manufacturing.
Details
News Market Reaction – SCTL
The recorded move for SCTL in the trading session of this news was +14.43%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Webcast Scheduled for Wednesday, August 10, 2022, at 4:30 p.m. Eastern
SAN DIEGO, Calif. and GAINESVILLE, Ga., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that the company will release financial results for the second quarter 2022 after the market close on Wednesday, August 10, 2022. Societal’s management team will host a webcast at 4:30 p.m. ET on Wednesday, August 10, 2022, to discuss the financial results and recent operational highlights.
A live webcast can be accessed by visiting the “Investor Events” page in the Investor section of the company’s website: https://ir.societalcdmo.com/events. In addition, an archived webcast will be available on the company’s website approximately two hours after the event and will be available for 30 days.
About Societal CDMO
Societal CDMO (NASDAQ: SCTL) is a bi-coastal contract development and manufacturing organization (CDMO) with capabilities spanning pre-Investigational New Drug (IND) development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in the area of small molecules. With an expertise in solving complex manufacturing problems, Societal CDMO is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market.
In addition to our experience in handling DEA controlled substances and developing and manufacturing modified-release dosage forms, Societal CDMO has the expertise to deliver on our clients’ pharmaceutical development and manufacturing projects, regardless of complexity level. We do all of this in our best-in-class facilities, which total 145,000 square feet, in Gainesville, Georgia and San Diego, California.
Societal CDMO: Bringing Science to Society. For more information about Societal CDMO’s customer solutions, visit societalcdmo.com.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.